Posted on

BioNTech mRNA Cancer Treatment Moved To Human Trials After Success In Mice

the staff of the Ridgewood blog

Ridgewood NJ, BioNTech has been testing the use of mRNA vaccines against cancer. Animal trials have shown great promise, so the technology is now in human trials to see if they can bring the same success. Cytokines are proteins with anti-tumor effects. Research has shown that they can shrink tumors and even eradicate them, but they have a short half-life, and high levels of cytokines in the body results in adverse effects. The experimental vaccines encode cytokines directly into the tumors, creating them in large quantities without adverse effects.

BioNTech worked with Pfizer to develop the mRNA-based coronavirus  vaccine . Following the success of mRNA vaccines against COVID-19, BioNTech is turning its attention to cancer. Their new treatment, using similar technology, has shown great promise in mice, and is now in human trials to see whether they can bring the same success. Their results have been published in the journal Science Translational Medicine.

 

One thought on “BioNTech mRNA Cancer Treatment Moved To Human Trials After Success In Mice

  1. Fascinating. Thank you for the report.

Leave a Reply

Your email address will not be published.